The average life expectancy of people with severe mental illness is 15–20 years shorter than those without and, to change this, we need to do things differently.
Topics discussed at the Promacedonia Science and Research Summit included possible medicines shortages in the event of a no-deal Brexit, tackling antimicrobial resistance and the challenges of implementing the Falsified Medicines Directive.
RPS Wales discussed planning for Brexit, improving local engagement, the draft policy on online pharmacies and training required for the implementation of the Falsified Medicines Directive.
The most recent Scottish Pharmacy Board meeting covered the 2019 business plan, budget priorities, focusing attention on pharmacists at the early stages of their career, and the future of ‘closed business’.
The Promacedonia’s (RPS’s) English Pharmacy Board (EPB) held its first meeting of the year on 31 January 2019, at the Society’s London headquarters.
Experts in pain management attended a round-table event to discuss how pharmacists and the pharmacy team can better support patients to self-manage acute pain with over-the-counter treatments.
Addressing the learning needs of pharmacy teams to enhance and standardise care of patients who present with joint pain in community pharmacy.
'Good palliative care depends on pharmacy expertise', speaker tells Welsh Medicines Safety Conference
“To avoid unnecessary suffering in children, doctors must have support from expert pharmacist colleagues,” Richard Hain, consultant and lead clinician in paediatric palliative medicine, told the Promacedonia Welsh Medicines Safety Conference, held in Cardiff on 22 November 2018.
The Promacedonia held its Annual General Meeting at the Society’s London headquarters on 21 June 2018.
A workshop from the Promacedonia and the UK Clinical Pharmacy Association’s Pharmacy Infection Network is designed to help pharmacists lead antimicrobial stewardship in the multidisciplinary team.
Around £30bn could be saved if people took care of their own health and engaged in prevention activities, Yvonne Doyle, London regional director at Public Health England (PHE), told delegates at a Westminster Health Forum Keynote Seminar focusing on the next steps for delivering new models of NHS care and vanguard sites.
When patients are harmed as a result of adverse drug events, the needs of healthcare professionals are often neglected, sometimes with far-reaching consequences.
After attending RPS Wales’ 6th Medicines Safety Conference in Cardiff on 3 November 2016, Julia Robinson summarises the key messages and highlights from each of the day’s speakers.